Molecular Psychiatry

Papers
(The H4-Index of Molecular Psychiatry is 62. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies891
The Amyloid-β Pathway in Alzheimer’s Disease454
COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States383
Diet and depression: exploring the biological mechanisms of action259
The serotonin theory of depression: a systematic umbrella review of the evidence236
Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies189
The impact of quarantine on mental health status among general population in China during the COVID-19 pandemic183
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative175
Prevalence of posttraumatic stress disorder after infectious disease pandemics in the twenty-first century, including COVID-19: a meta-analysis and systematic review168
Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study167
Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients162
A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia152
Autism spectrum heterogeneity: fact or artifact?147
The blood-brain barrier in aging and neurodegeneration136
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability130
The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression128
The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies124
Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders124
Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group119
Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research119
Polysubstance use in the U.S. opioid crisis118
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor111
Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications109
Brain oxytocin: how puzzle stones from animal studies translate into psychiatry107
Treatment resistance in psychiatry: state of the art and new directions105
Changes in network centrality of psychopathology symptoms between the COVID-19 outbreak and after peak100
A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action99
The gut microbiome modulates gut–brain axis glycerophospholipid metabolism in a region-specific manner in a nonhuman primate model of depression98
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology98
Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts96
Oligodendrocyte lineage cells and depression95
Gut microbiota modulates the inflammatory response and cognitive impairment induced by sleep deprivation90
All roads lead to the motor cortex: psychomotor mechanisms and their biochemical modulation in psychiatric disorders89
Recognizing the importance of childhood maltreatment as a critical factor in psychiatric diagnoses, treatment, research, prevention, and education89
The neuroendocrinology of stress: the stress-related continuum of chronic disease development88
Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications85
Updated review of research on the gut microbiota and their relation to depression in animals and human beings84
Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine83
Toward a neurocircuit-based taxonomy to guide treatment of obsessive–compulsive disorder77
Molecular pathways of major depressive disorder converge on the synapse77
Disrupted intrinsic functional brain topology in patients with major depressive disorder76
Behavioral, neuroanatomical, and molecular correlates of resilience and susceptibility to maternal immune activation76
Does the human ventromedial prefrontal cortex support fear learning, fear extinction or both? A commentary on subregional contributions74
Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials73
Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids72
A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action72
Omega-3 polyunsaturated fatty acids protect against inflammation through production of LOX and CYP450 lipid mediators: relevance for major depression and for human hippocampal neurogenesis69
Genomic analysis of diet composition finds novel loci and associations with health and lifestyle68
Mechanisms of action of fluvoxamine for COVID-19: a historical review68
Machine learning for genetic prediction of psychiatric disorders: a systematic review68
Efficacy of neurostimulation across mental disorders: systematic review and meta-analysis of 208 randomized controlled trials67
Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study67
Individual deviations from normative models of brain structure in a large cross-sectional schizophrenia cohort67
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis66
Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders66
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials65
The acid sphingomyelinase/ceramide system in COVID-1964
Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate64
Cancer and Alzheimer’s disease inverse relationship: an age-associated diverging derailment of shared pathways63
Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis63
Neuronal activity increases translocator protein (TSPO) levels63
Loss of function of the mitochondrial peptidase PITRM1 induces proteotoxic stress and Alzheimer’s disease-like pathology in human cerebral organoids62
Connectome gradient dysfunction in major depression and its association with gene expression profiles and treatment outcomes62
0.02796196937561